pyrrolidine dithiocarbamate has been researched along with Breast Cancer in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, NF; Chuang, SK; Lee, YJ; Lin, WL; Tseng, TH | 1 |
Cheng, X; He, L; Li, D; Sun, M; Tang, R; Wang, X; Zheng, Y | 1 |
Busby, B; Covington, J; Gu, JW; Johnson, JW; Young, E | 1 |
Bang, JS; Choi, HM; Kim, KS; Oh, DH; Yang, HI; Yoo, MC | 1 |
Dou, QP; Li, L; Liu, X; Wang, F; Wu, S; Yan, B; Zhai, S | 1 |
Huang, W; Lin, Q; Wei, H; Yang, C; Zhang, H | 1 |
Fu, ZY; Lv, JH; Ma, CY; Wang, T; Yang, DP | 1 |
Chen, D; Cui, QC; Daniel, KG; Dou, QP; Miller, FR; Orlu, S | 1 |
Bai, J; Gu, P; Margolick, JB; Zhang, H; Zhang, Y; Zhou, J | 1 |
Furuta, S; Mason, A; Momand, J; Ortiz, F; Wu, HH; Zhu Sun, X | 1 |
10 other study(ies) available for pyrrolidine dithiocarbamate and Breast Cancer
Article | Year |
---|---|
Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Movement; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mice; Mice, Nude; Molecular Structure; Neoplasm Invasiveness; Signal Transduction; Structure-Activity Relationship; Tumor Cells, Cultured | 2012 |
Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cells, Cultured; Doxorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; HEK293 Cells; Humans; Hydrodynamics; Hydrogen-Ion Concentration; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Polymers; Pyrrolidines; Surface Properties; Thiocarbamates | 2019 |
Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis, and growth of breast cancer in female mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Synergism; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Indoles; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; NF-kappa B; Pyrroles; Pyrrolidines; Thiocarbamates; Tumor Burden; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2009 |
Fetal bovine serum requirement for pyrrolidine dithiocarbamate-induced apoptotic cell death of MCF-7 breast tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blood Proteins; Breast Neoplasms; Cattle; Cell Line, Tumor; Cell Survival; Chelating Agents; Culture Media; Dialysis; Enzyme Inhibitors; Female; Fetal Blood; Humans; NF-kappa B; Proteasome Inhibitors; Pyrrolidines; Serum; Thiocarbamates; Zinc | 2010 |
A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells.
Topics: Aldehyde Dehydrogenase; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Copper; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Proteasome Inhibitors; Pyrrolidines; Thiocarbamates | 2011 |
[Effect of combined use of PDTC and paclitaxel on proliferation and invasion of human breast cancer cell line MCF-7].
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Humans; Neoplasm Invasiveness; NF-kappa B; Paclitaxel; Pyrrolidines; Thiocarbamates | 2010 |
Tissue inhibitor of metalloproteinase-1 decreased chemosensitivity of MDA-435 breast cancer cells to chemotherapeutic drugs through the PI3K/AKT/NF-кB pathway.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Chromones; Epirubicin; Female; Humans; Morpholines; NF-kappa B; Paclitaxel; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrrolidines; Signal Transduction; Thiocarbamates; Tissue Inhibitor of Metalloproteinase-1 | 2011 |
Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.
Topics: Anti-Infective Agents, Local; Antioxidants; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Clioquinol; Copper; Drug Interactions; Female; Humans; Precancerous Conditions; Proteasome Inhibitors; Pyrrolidines; Thiocarbamates | 2005 |
NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Ditiocarb; Female; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; NF-kappa B; Paclitaxel; Pyrrolidines; Sesquiterpenes; Spheroids, Cellular; Thiocarbamates; Time Factors; Xenograft Model Antitumor Assays | 2008 |
Copper uptake is required for pyrrolidine dithiocarbamate-mediated oxidation and protein level increase of p53 in cells.
Topics: Animals; Antioxidants; Breast Neoplasms; Cells, Cultured; Chelating Agents; Copper; Cysteine; Cysteine Proteinase Inhibitors; Ditiocarb; Female; Fibroblasts; Free Radicals; Humans; Hydrogen Peroxide; Leupeptins; Mannitol; Molecular Structure; Oxidants; Oxidation-Reduction; Pyrrolidines; Rats; Recombinant Proteins; Thiobarbituric Acid Reactive Substances; Thiocarbamates; Tumor Suppressor Protein p53 | 2002 |